1. Targeting the Interplay between Epithelial-to-Mesenchymal-Transition and the Immune System for Effective Immunotherapy
   Rama Soundararajan et al, 2019, Cancers CrossRef
2. The Mechanisms of PD-L1 Regulation in Non-Small-Cell Lung Cancer (NSCLC): Which Are the Involved Players?
   Giuseppe Lamberti et al, 2020, Cancers CrossRef
3. The Molecular Role of IL-35 in Non-Small Cell Lung Cancer
   Yuqiu Hao et al, 2022, Frontiers in Oncology CrossRef
4. Reversal of Chemotherapy Resistance to Cisplatin in NSCLC by miRNA-195-5p via Targeting the FGF2 Gene
   Hao Wang et al, 2021, Pharmacogenomics and Personalized Medicine CrossRef
5. Theoretical Substantiation of Personalized (Target) Therapy of Testicular Germ Cell Tumors
   null null et al, 2020, Ukraïnsʹkij žurnal medicini, bìologìï ta sportu CrossRef
6. Phosphate Toxicity and Epithelial to Mesenchymal Transition
   Eric Lewis et al, 2022, Phosphate Metabolism CrossRef
7. Clinical Impact of the Epithelial-Mesenchymal Transition in Lung Cancer as a Biomarker Assisting in Therapeutic Decisions
   Julien Ancel et al, 2022, Cells Tissues Organs CrossRef
8. Programmed Death–Ligand 1 and Vimentin: A Tandem Marker as Prognostic Factor in NSCLC
   Julien Ancel et al, 2019, Cancers CrossRef
9. Non-apoptotic activity of the mitochondrial protein SMAC/Diablo in lung cancer: Novel target to disrupt survival, inflammation, and immunosuppression
   Swaroop Kumar Pandey et al, 2022, Frontiers in Oncology CrossRef